Investing.com-- Most Asian stocks rose marginally on Thursday amid increased hopes for a deescalation in U.S. President Donald Trump’s tariff agenda ahead of trade talks between Washington and Beijing ...

Uncertainty over Trump’s tariffs was a key weight on oil prices in recent weeks, as markets fretted over their potential impact. Oil was also rattled by a slew of recent economic readings showing ...

Investing.com-- U.S. President Donald Trump said on Wednesday that he will announce a trade deal with a major country on ...

Fewer export restrictions will benefit U.S.-based chipmakers, allowing them to sell more advanced chips overseas. AI chip ...

For fiscal 2025, Amdocs now expects revenue to decline between 10.9% and 9.1% as reported. On a pro forma constant currency ...

Cleveland-Cliffs’ Q1 performance was negatively impacted by underperforming non-core assets and lagging effects of lower index prices from late 2024 and early 2025. In response, the company announced ...

The gaming technology company posted adjusted earnings per share of $0.94, missing the consensus estimate of $1.11. Revenue came in at $774 million, below analyst projections of $806.04 million.

The company posted revenue of $549.65 million for the quarter ended March 29, 2025, beating analyst estimates of $522.43 million and marking a 40% increase YoY. However, Symbotic reported an adjusted ...

The strong results were driven by growth across all business segments. Corporate Finance revenues jumped 44% YoY to $412.7 million in Q4, while Financial Restructuring revenues rose 6% to $164.5 ...

Investing.com -- IonQ (NYSE: IONQ ), a leading commercial quantum computing and networking company, reported first-quarter revenue above the midpoint of its guidance range, while its earnings per ...

AppLovin (NASDAQ:APP) rose 14% after first quarter results beat estimates and it delivered strong guidance. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.38 ...

Investing.com -- President Donald Trump is set to revive an initiative aimed at drastically reducing drug costs by linking ...